Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma.

Scheiner B, Kirstein M, Popp S, Hucke F, Bota S, Rohr-Udilova N, Reiberger T, Müller C, Trauner M, Peck-Radosavljevic M, Vogel A, Sieghart W, Pinter M.

Liver Cancer. 2019 May;8(3):203-217. doi: 10.1159/000489833. Epub 2018 Jun 22.

2.

Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response.

Caruso S, Calatayud AL, Pilet J, La Bella T, Rekik S, Imbeaud S, Letouzé E, Meunier L, Bayard Q, Rohr-Udilova N, Péneau C, Grasl-Kraupp B, de Koning L, Ouine B, Bioulac-Sage P, Couchy G, Calderaro J, Nault JC, Zucman-Rossi J, Rebouissou S.

Gastroenterology. 2019 Sep;157(3):760-776. doi: 10.1053/j.gastro.2019.05.001. Epub 2019 May 4.

PMID:
31063779
3.

The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats.

Schwabl P, Brusilovskaya K, Supper P, Bauer D, Königshofer P, Riedl F, Hayden H, Fuchs CD, Stift J, Oberhuber G, Aschauer S, Bonderman D, Gnad T, Pfeifer A, Uschner FE, Trebicka J, Rohr-Udilova N, Podesser BK, Peck-Radosavljevic M, Trauner M, Reiberger T.

Sci Rep. 2018 Jun 19;8(1):9372. doi: 10.1038/s41598-018-27656-y.

4.

Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma.

Rohr-Udilova N, Klinglmüller F, Schulte-Hermann R, Stift J, Herac M, Salzmann M, Finotello F, Timelthaler G, Oberhuber G, Pinter M, Reiberger T, Jensen-Jarolim E, Eferl R, Trauner M.

Sci Rep. 2018 Apr 18;8(1):6220. doi: 10.1038/s41598-018-24437-5.

5.

Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinoma.

Rohr-Udilova N, Bauer E, Timelthaler G, Eferl R, Stolze K, Pinter M, Seif M, Hayden H, Reiberger T, Schulte-Hermann R, Peck-Radosavljevic M, Stoiber D, Trauner M.

Oncotarget. 2018 Jan 22;9(11):10054-10068. doi: 10.18632/oncotarget.24300. eCollection 2018 Feb 9.

6.

Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib.

Rohr-Udilova N, Klinglmüller F, Seif M, Hayden H, Bilban M, Pinter M, Stolze K, Sieghart W, Peck-Radosavljevic M, Trauner M.

Oncotarget. 2017 Jul 6;8(34):57109-57120. doi: 10.18632/oncotarget.19055. eCollection 2017 Aug 22.

7.

Photoactivation provides a mechanistic explanation for pan-assay interference behaviour of 2-aminopyrroles in lipoxygenase inhibition.

Guo H, Eleftheriadis N, Rohr-Udilova N, Dömling A, Dekker FJ.

Eur J Med Chem. 2017 Oct 20;139:633-643. doi: 10.1016/j.ejmech.2017.07.047. Epub 2017 Jul 24.

PMID:
28843180
8.

Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro.

Rebouissou S, La Bella T, Rekik S, Imbeaud S, Calatayud AL, Rohr-Udilova N, Martin Y, Couchy G, Bioulac-Sage P, Grasl-Kraupp B, de Koning L, Ganne-Carrié N, Nault JC, Ziol M, Zucman-Rossi J.

Clin Cancer Res. 2017 Aug 1;23(15):4364-4375. doi: 10.1158/1078-0432.CCR-16-3118. Epub 2017 Feb 28.

9.

The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction.

Schwabl P, Hambruch E, Seeland BA, Hayden H, Wagner M, Garnys L, Strobel B, Schubert TL, Riedl F, Mitteregger D, Burnet M, Starlinger P, Oberhuber G, Deuschle U, Rohr-Udilova N, Podesser BK, Peck-Radosavljevic M, Reiberger T, Kremoser C, Trauner M.

J Hepatol. 2017 Apr;66(4):724-733. doi: 10.1016/j.jhep.2016.12.005. Epub 2016 Dec 18.

10.

Metabolic preconditioning protects BSEP/ABCB11-/- mice against cholestatic liver injury.

Fuchs CD, Paumgartner G, Wahlström A, Schwabl P, Reiberger T, Leditznig N, Stojakovic T, Rohr-Udilova N, Chiba P, Marschall HU, Trauner M.

J Hepatol. 2017 Jan;66(1):95-101. doi: 10.1016/j.jhep.2016.08.017. Epub 2016 Sep 1.

11.

Food-derived peroxidized fatty acids may trigger hepatic inflammation: a novel hypothesis to explain steatohepatitis.

Böhm T, Berger H, Nejabat M, Riegler T, Kellner F, Kuttke M, Sagmeister S, Bazanella M, Stolze K, Daryabeigi A, Bintner N, Murkovic M, Wagner KH, Schulte-Hermann R, Rohr-Udilova N, Huber W, Grasl-Kraupp B.

J Hepatol. 2013 Sep;59(3):563-70. doi: 10.1016/j.jhep.2013.04.025. Epub 2013 May 9.

PMID:
23665282
12.

Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma.

Sieghart W, Pinter M, Dauser B, Rohr-Udilova N, Piguet AC, Prager G, Hayden H, Dienes HP, Dufour JF, Peck-Radosavljevic M.

J Hepatol. 2012 Sep;57(3):592-9. doi: 10.1016/j.jhep.2012.04.034. Epub 2012 May 24.

PMID:
22634341
13.

Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma.

Rohr-Udilova N, Sieghart W, Eferl R, Stoiber D, Björkhem-Bergman L, Eriksson LC, Stolze K, Hayden H, Keppler B, Sagmeister S, Grasl-Kraupp B, Schulte-Hermann R, Peck-Radosavljevic M.

Hepatology. 2012 Apr;55(4):1112-21. doi: 10.1002/hep.24808.

PMID:
22105228
14.

Synthesis and characterization of 5-alkoxycarbonyl-4-hydroxymethyl-5-alkyl-pyrroline N-oxide derivatives.

Patel A, Rohr-Udilova N, Rosenau T, Stolze K.

Bioorg Med Chem. 2011 Dec 15;19(24):7643-52. doi: 10.1016/j.bmc.2011.10.017. Epub 2011 Oct 18.

PMID:
22094277
15.

The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma--a pilot study.

Pinter M, Sieghart W, Reiberger T, Rohr-Udilova N, Ferlitsch A, Peck-Radosavljevic M.

Aliment Pharmacol Ther. 2012 Jan;35(1):83-91. doi: 10.1111/j.1365-2036.2011.04896.x. Epub 2011 Oct 27.

16.

Synthesis and characterization of 5-hydroxymethyl-5-methyl-pyrroline N-oxide and its derivatives.

Stolze K, Rohr-Udilova N, Patel A, Rosenau T.

Bioorg Med Chem. 2011 Jan 15;19(2):985-93. doi: 10.1016/j.bmc.2010.11.052. Epub 2010 Nov 26.

PMID:
21211983
17.

Synthesis and characterization of several carbamoyl- and methylcarbamoyl-substituted EMPO derivatives.

Stolze K, Rohr-Udilova N, Hofinger A, Rosenau T.

Bioorg Med Chem. 2009 Nov 1;17(21):7572-84. doi: 10.1016/j.bmc.2009.09.006. Epub 2009 Sep 6.

PMID:
19800243
18.

Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.

Reiberger T, Angermayr B, Schwabl P, Rohr-Udilova N, Mitterhauser M, Gangl A, Peck-Radosavljevic M.

J Hepatol. 2009 Nov;51(5):865-73. doi: 10.1016/j.jhep.2009.06.024. Epub 2009 Aug 4.

PMID:
19726100
19.

HB-EGF is a paracrine growth stimulator for early tumor prestages in inflammation-associated hepatocarcinogenesis.

Sagmeister S, Drucker C, Losert A, Grusch M, Daryabeigi A, Parzefall W, Rohr-Udilova N, Bichler C, Smedsrød B, Kandioler D, Grünberger T, Wrba F, Schulte-Hermann R, Grasl-Kraupp B.

J Hepatol. 2008 Dec;49(6):955-64. doi: 10.1016/j.jhep.2008.06.031. Epub 2008 Oct 7.

PMID:
18929421
20.

Spin trapping experiments with different carbamoyl-substituted EMPO derivatives.

Stolze K, Rohr-Udilova N, Hofinger A, Rosenau T.

Bioorg Med Chem. 2008 Sep 1;16(17):8082-9. doi: 10.1016/j.bmc.2008.07.057. Epub 2008 Jul 25.

PMID:
18706818
21.

Lipid hydroperoxides from processed dietary oils enhance growth of hepatocarcinoma cells.

Rohr-Udilova NV, Stolze K, Sagmeister S, Nohl H, Schulte-Hermann R, Grasl-Kraupp B.

Mol Nutr Food Res. 2008 Mar;52(3):352-9. doi: 10.1002/mnfr.200700149.

PMID:
18293301
22.

The dietary antioxidants resveratrol and quercetin protect cells from exogenous pro-oxidative damage.

Kaindl U, Eyberg I, Rohr-Udilova N, Heinzle C, Marian B.

Food Chem Toxicol. 2008 Apr;46(4):1320-6. Epub 2007 Sep 11.

PMID:
17936464
23.

Cytotoxicity of the novel spin trapping compound 5-ethoxycarbonyl-3,5-dimethyl-pyrroline N-oxide (3,5-EDPO) and its derivatives.

Rohr-Udilova N, Stolze K, Sagmeister S, Parzefall W, Marian B, Nohl H, Schulte-Hermann R, Grasl-Kraupp B.

Bioorg Med Chem Lett. 2007 Oct 15;17(20):5698-703. Epub 2007 Aug 19.

PMID:
17804223
24.

Free radical trapping properties of several ethyl-substituted derivatives of 5-ethoxycarbonyl-5-methyl-1-pyrroline N-oxide (EMPO).

Stolze K, Rohr-Udilova N, Rosenau T, Hofinger A, Nohl H.

Bioorg Med Chem. 2007 Apr 15;15(8):2827-36. Epub 2007 Feb 15.

PMID:
17336073
25.

Ubiquinol and the papaverine derivative caroverine prevent the expression of tumour- promoting factors in adenoma and carcinoma colon cancer cells induced by dietary fat.

Nohl H, Rohr-Udilova N, Gille L, Bieberschulte W, Jurek D, Marian B, Schulte-Hermann R.

Biofactors. 2005;25(1-4):87-95.

PMID:
16873933
26.

Spin trapping of C- and O-centered radicals with methyl-, ethyl-, pentyl-, and phenyl-substituted EMPO derivatives.

Stolze K, Rohr-Udilova N, Rosenau T, Hofinger A, Kolarich D, Nohl H.

Bioorg Med Chem. 2006 May 15;14(10):3368-76. Epub 2006 Jan 24.

PMID:
16439134
27.

Cytotoxicity of novel derivatives of the spin trap EMPO.

Rohr-Udilova N, Stolze K, Marian B, Nohl H.

Bioorg Med Chem Lett. 2006 Feb;16(3):541-6. Epub 2005 Nov 10.

PMID:
16289821
28.

Suppression of tumour-promoting factors in fat-induced colon carcinogenesis by the antioxidants caroverine and ubiquinone.

Nohl H, Rohr-Udilova N, Gille L, Bieberschulte W, Jurek D, Marian B, Schulte-Herman R.

Anticancer Res. 2005 Jul-Aug;25(4):2793-800.

29.

Very stable superoxide radical adducts of 5-ethoxycarbonyl- 3,5-dimethyl-pyrroline N-oxide (3,5-EDPO) and its derivatives.

Stolze K, Rohr-Udilova N, Rosenau T, Stadtmüller R, Nohl H.

Biochem Pharmacol. 2005 May 1;69(9):1351-61.

PMID:
15826606

Supplemental Content

Loading ...
Support Center